Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Introduction
00:00 • 2min
The Market Outlook for the NASDAQ and S&P 500
01:37 • 4min
The Market's Path to Recovery in the Healthcare Sector
05:55 • 3min
The NASDAQ Composite and the Breakdown Over 12,000
08:47 • 2min
The S&P 500's Distribution Day
10:43 • 4min
The S&P 500 Equal Weighted ETF Is Showing a Different Picture on Its Advanced Decline Line
15:00 • 2min
The Prospects for the Healthcare, Medical Area
17:17 • 3min
How to Invest in the Healthcare Sector
20:25 • 3min
Market Smith: A Great Way to Evaluate an Industry Group
23:41 • 3min
How to Avoid Speculative Names in Biotechs
26:29 • 2min
The Implications of Biotech Innovations
28:21 • 4min
Bill O'Neill's Path to Business
32:43 • 3min
The North Coast Concentrated Stock Triple Play Strategy
35:19 • 2min
The Medical Products Industry Group
36:55 • 5min
ResMed: A New Treatment for Sleep Apnea
42:22 • 2min
Dexcom DX, CM, and Inspire Medical: A Stock That's Coming Off a Sharp Selloff
43:59 • 3min
Dexcom's Over Owned Position Means There's Still a Fear of Over Owning
46:39 • 2min
Dexcom's Stocks in the Diabetes Group
48:12 • 3min
Ion Endoluminal System
51:36 • 4min
Ed Carson on the Healthcare Sector
55:45 • 2min